Tranexamic Acid for the Management of Obstetric Hemorrhage
- PMID: 29189683
- DOI: 10.1097/AOG.0000000000002384
Tranexamic Acid for the Management of Obstetric Hemorrhage
Comment in
-
In Reply.Obstet Gynecol. 2017 Dec;130(6):1386-1387. doi: 10.1097/AOG.0000000000002385. Obstet Gynecol. 2017. PMID: 29189684 No abstract available.
Comment on
-
Tranexamic Acid for the Management of Obstetric Hemorrhage.Obstet Gynecol. 2017 Oct;130(4):765-769. doi: 10.1097/AOG.0000000000002253. Obstet Gynecol. 2017. PMID: 28885402
References
-
- Pacheco LD, Hankins GDV, Saad AF, Costantine MM, Chiossi G, Saade GR. Tranexamic acid for the management of obstetric hemorrhage. Obstet Gynecol 2017;130:765–9.
-
- WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;10084:2105–16.
-
- Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011–2013. Obstet Gynecol 2017;2:366–73.
-
- Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH. Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet Gynecol 2013;4:752–60.
-
- Kruithof EK, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987;2:460–6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources